Associate Director, Financial Planning & Analysis - Commercial

POSITION SUMMARY:

As Intercept continues to build its position as the leader in rare and serious liver disease, we are seeking an Associate Director, Financial Planning & Analysis (FP&A) �� Commercial. The Associate Director of FP&A is responsible for business partnering, driving financial accountability, strategic resource allocation, performance analysis, and reporting for Intercept’s Commercial function. The position partners with functional and FP&A leadership while also working cross-functionally with multiple stakeholders to provide financial support to optimize strategic financial decision making and establish and track financial targets.

JOB RESPONSIBILITIES:

• Effectively partner with Intercept’s Commercial functions to coordinate short-, mid- and long-term financial planning, including both revenue and operating expenses

• Lead the annual budgeting and planning processes (including Budget, 5+7) for the Commercial function

• Perform necessary duties, in conjunction with FP&A, Accounting, and business stakeholders to support monthly close within designated timelines for Commercial

• Ensure accurate monthly reporting to Intercept Finance leadership, Commercial leadership, and other appropriate stakeholders across the organization, including global Alfasigma functions

• Ensure forecasting accuracy and partner with global Alfasigma leadership, Intercept leadership, Commercial leadership, and other business stakeholders to track and monitor variances, risks, and opportunities throughout the year

• Lead and work cross-functionally to support reporting for appropriate Commercial leadership team meetings; identify and drive enhancements in this process not only for Intercept stakeholders, but more broadly for Alfasigma, as necessary

• Identify opportunities to improve and streamline existing business processes and decision making

• Prepare high-quality presentation materials appropriate for use during leadership meetings; effectively synthesize financial data to deliver insights that clearly communicate performance

• Collaborate with global Alfasigma Procurement to champion cost savings opportunities and support vendor negotiations

Requirements

QUALIFICATIONS:

• Bachelor’s degree required

• 7+ years of overall professional experience, ideally with a broad range of financial planning, reporting, and systems management experience

• Prior experience partnering with Commercial organizations required; experience managing revenue forecasting strongly preferred

• Experience utilizing financial reporting tools for budget, forecast, and reporting processes

REQUIRED KNOWLEDGE AND ABILITIES:

• Ability to work in the Morristown, NJ office on a hybrid basis (minimum 2 days per week)

• Working knowledge of US healthcare/pharmaceuticals market

• Working knowledge of US GAAP

• Knowledge of financial reporting and analytical systems (such as TM1, Microsoft Excel, PowerPoint, and Word)

• Ability to think strategically to challenge and improve current processes

• Ability to translate financial concepts and to effectively collaborate with colleagues who do not have finance backgrounds

• Ability to work effectively across a matrixed organization by prioritizing and meeting deadlines in a fast-paced environment

• Ability to work independently and prioritize with minimal daily instruction

• Excellent leadership and business partnering skills

• Strong verbal and written communications skills with the ability to partner

• Commitment to talent development to maximize individual and organizational goals

• Learning agility and ‘scalability’ to take on increasing responsibility as Intercept grows

• Consistent demonstration and embodiment of our Corporate Beliefs: Passion for Innovation; Think Big, Act Small; Learn to Dare; and Teams Build the Future

• Ability to have fun and thrive in a growing, diverse, and inclusive work environment

Benefits

ABOUT INTERCEPT:

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with rare and serious liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs.

People at Intercept are passionate about patients. You’ll see our patient photos lining our walls and hear their stories in town halls. We’re equally passionate about our team, ensuring each member feels included an